Mathilde Grande

Cancer drug assessment: What is driving high clinical added value in France?

L. Guillevin, Judith Fernandez, Mathilde Grande, 2017 .

Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment.

S. Chevret, F. Gueyffier, F. Degos, 2021, The Lancet Oncology.

How can a joint European health technology assessment provide an ‘additional benefit’ over the current standard of national assessments?

O. Solà-Morales, P. Mol, T. Salmonson, 2022, Health Economics Review.

Shaping a research agenda to ensure a successful European health technology assessment: insights generated during the inaugural convention of the European access academy

O. Solà-Morales, P. Mol, M. Pavlovic, 2022, Health Economics Review.